Energy Voice | Rotech marks 500th job

An Aberdeen-based subsea technology firm is celebrating a double milestone after completing its 500th project in its 25th year.

Rotech Subsea, which started operations under the Rotech Group banner in 1994, notched up its 500th job during a hectic May.

It said yesterday it completed four “major” projects during the month, with two vessels setting off from Aberdeen with its innovative subsea systems within nine days.

The 500th project saw Rotech Subsea despatch its TRS1-LD controlled flow excavation system for cable post-trenching work off the coast of Germany for long-term client Jan De Nul Group.

Projects completed during May alone were worth more than £1 million to the firm, which recently set up a subsidiary and opened an office in Kuala Lumpur, Malaysia, to meet growing demand in Asia.

A spike in demand for its trenching and excavation technology led to an accelerated order for sister company Rotech Fabrication to build new equipment for a key client.

Rotech Subsea director Stephen Cochrane said the business was benefiting from a long and successful track record.

He added: “Rotech Group has, since its inception nearly 25 years ago, earned a reputation as being a pioneer in the development of cutting-edge controlled flow excavation. It’s a reputation we are proud of and that we continue to build on, operating across the renewables, oil and gas and decommissioning sectors for a growing list of clients.

“We are delighted to have passed the 500th project mark. More than that, this milestone project also contributed to an extremely strong finish to our financial year.”
Group accounts for the year to June 30 2017 are still being finalised but Mr Cochrane said subsea revenue doubled amid “some of the most challenging times in recent memory”.

He added: “Demand has been high, driven by a combination of winning new business and retaining key clients.”

Rotech Subsea is preparing to transport equipment for new projects in the North Sea, Mexico, Vietnam and Middle East.

Mr Cochrane was part of a management buyout of Rotech Group in 2016, along with Martin Graham, Steve Aitken, chairman Mike Hill and existing shareholder Don Stewart.

Source link